Holen Sie sich die Stockscreener-App
18.80
0.59%
0.11
Schlusskurs vom Vortag:
$18.69
Offen:
$18.87
24-Stunden-Volumen:
12,405
Relative Volume:
3.69
Marktkapitalisierung:
$454.37M
Einnahmen:
$1.70M
Nettoeinkommen (Verlust:
$-47.01M
KGV:
-11.06
EPS:
-1.7
Netto-Cashflow:
$-157.28M
1W Leistung:
+0.70%
1M Leistung:
+12.98%
6M Leistung:
-1.51%
1J Leistung:
-3.59%
1-Tages-Spanne:
$18.65
$18.98
1-Wochen-Bereich:
$18.31
$19.11
52-Wochen-Spanne:
$13.30
$20.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Firmenname
Puretech Health Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
18.80 | 451.71M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.07 | 119.76B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.29 | 79.35B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
848.02 | 51.71B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.03 | 44.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
345.19 | 38.18B | 4.98B | 69.60M | 525.67M | 0.5198 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
Puretech Health Plc Adr Aktie (PRTC) Neueste Nachrichten
PureTech Health (NASDAQ:PRTC) Shares Up 2%Here's Why - MarketBeat
PRTC Stock Price and Chart — NASDAQ:PRTC - TradingView — Track All Markets
PureTech Health (NASDAQ:PRTC) Trading Up 5.7%Here's Why - MarketBeat
PureTech Health (NASDAQ:PRTC) Trading Up 5.7% – Here’s Why - Defense World
PureTech CEO to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech CEO to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Decrease in Short Interest - Defense World
PureTech Health appoints Robert Lyne as permanent CEO - Investing.com
PureTech Health appoints Robert Lyne as permanent CEO By Investing.com - Investing.com India
PureTech Health (NASDAQ:PRTC) Trading Down 0.7% – Time to Sell? - Defense World
PureTech Health (NASDAQ:PRTC) Trading Down 0.7%Time to Sell? - MarketBeat
PureTech provides update on AGM results following shareholder concerns - Investing.com
PureTech stock falls after FDA meeting on IPF drug - Investing.com
PureTech Health (NASDAQ:PRTC) Trading 0.4% HigherStill a Buy? - MarketBeat
PureTech Health (NASDAQ:PRTC) Stock Price Up 3.1%Time to Buy? - MarketBeat
PureTech Health PLC Sponsored ADR $PRTC Shares Sold by Birch Hill Investment Advisors LLC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 100.0% in September - MarketBeat
Free cash flow per share of PureTech Health PLC Sponsored ADR – NASDAQ:PRTC - TradingView
PureTech Health (NASDAQ:PRTC) Trading Up 3.6%Here's What Happened - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Significant Growth in Short Interest - MarketBeat
PureTech Health (LON:PRTC) Shares Up 14.2% – Should You Buy? - Defense World
PureTech Health Sees Strong Market Presence in FTSE All Share - Kalkine Media
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Large Growth in Short Interest - MarketBeat
BioHarvest Sciences (BHST) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
PureTech Health (NASDAQ:PRTC) Shares Up 4.7%Time to Buy? - MarketBeat
PureTech Health Cash Runway Extended - The Motley Fool
International Flavors & Fragrances (NYSE:IFF) & DAQO New Energy (NYSE:DQ) Critical Comparison - Defense World
Conference Calls and Individual Investors - MarketBeat
Deupirfenidone: A Potential New Standard of Care - Placera.se
PureTech launches new entity to advance IPF treatment deupirfenidone - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health to report half-yearly results on August 28 By Investing.com - Investing.com South Africa
PureTech Health (NASDAQ:PRTC) Trading Up 1.4% – Still a Buy? - Defense World
PureTech Health (NASDAQ:PRTC) Shares Down 7.3% – Here’s What Happened - Defense World
PureTech’s Seaport doses first patient in phase 2b depression study By Investing.com - Investing.com South Africa
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
Big Oil's Q2 Outlook: Downstream Gains and Upstream Pains - The Globe and Mail
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
Citius Oncology (CTOR) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
PureTech set for Jefferies Global Healthcare Conference chat - Investing.com
TuHURA Biosciences (HURA) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
PureTech Health enlists Peel Hunt as joint broker - Investing.com
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health (LSE: PRTC) Presents Promising Phase 1b Data for LYT-200 in AML and MDS at ASH 2024 - Kalkine Media
India Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Argentina Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Norway Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Finanzdaten der Puretech Health Plc Adr-Aktie (PRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):